🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Removal

Based on the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of slimming results, glowing reviews and detailed guides for mixing or administering at residence.

Within moments of entering one group, a vendor shared contact information, where the majority of transactions occur. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Item Information and Pricing

Within these groups, posts show black plastic packages with postal service labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they cannot confirm. Although the science behind this drug is valid, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly serious medical dangers”.